355 related articles for article (PubMed ID: 24833770)
1. Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
Takeda A; Oku Y; Sanuki N; Eriguchi T; Aoki Y; Enomoto T; Kaneko T; Nishimura S; Kunieda E
J Radiat Res; 2014 Sep; 55(5):988-95. PubMed ID: 24833770
[TBL] [Abstract][Full Text] [Related]
2. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.
Takeda A; Kunieda E; Sanuki N; Ohashi T; Oku Y; Sudo Y; Iwashita H; Ooka Y; Aoki Y; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):363-9. PubMed ID: 19427552
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
4. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
[TBL] [Abstract][Full Text] [Related]
5. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
[TBL] [Abstract][Full Text] [Related]
6. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
[TBL] [Abstract][Full Text] [Related]
7. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.
Ding C; Solberg TD; Hrycushko B; Xing L; Heinzerling J; Timmerman RD
Med Phys; 2013 May; 40(5):051705. PubMed ID: 23635253
[TBL] [Abstract][Full Text] [Related]
8. Full Dose SBRT in Combination With Mediastinal Chemoradiation for Locally Advanced, Non-Small Cell Lung Cancer: A Practical Guide for Planning, Dosimetric Results From a Phase 2 Study, and a Treatment Planning Guide for the Phase 3 NRG Oncology LU-008 Trial.
Heinzerling JH; Pen OV; Robinson M; Foster R; Kelly B; Mileham KF; Moeller B; Prabhu RS; Corso C; Ward MW; Sullivan CM; Burri S; Simone CB
Pract Radiat Oncol; 2023; 13(6):531-539. PubMed ID: 37406774
[TBL] [Abstract][Full Text] [Related]
9. Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors.
Mitsuyoshi T; Matsuo Y; Shintani T; Iizuka Y; Ueki N; Nakamura M; Mizowaki T
Clin Lung Cancer; 2018 May; 19(3):e287-e296. PubMed ID: 29277565
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.
Oku Y; Takeda A; Sanuki N; Sudo Y; Oooka Y; Aoki Y; Shimouchi Y; Nishina R; Nomura K; Eriguchi T; Kunieda E
Pract Radiat Oncol; 2014; 4(1):e7-e13. PubMed ID: 24621435
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.
Iwata H; Ishikura S; Murai T; Iwabuchi M; Inoue M; Tatewaki K; Ohta S; Yokota N; Shibamoto Y
Int J Clin Oncol; 2017 Aug; 22(4):706-714. PubMed ID: 28429140
[TBL] [Abstract][Full Text] [Related]
13. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
14. Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates.
Yamashita H; Haga A; Takahashi W; Takenaka R; Imae T; Takenaka S; Nakagawa K
Radiat Oncol; 2014 Nov; 9():243. PubMed ID: 25385062
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pencil beam-based homogeneous vs inhomogeneous target dose planning for stereotactic body radiotherapy of peripheral lung tumors through Monte Carlo-based recalculation.
Ohtakara K; Hoshi H
Med Dosim; 2015; 40(3):248-55. PubMed ID: 25776903
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.
Owen D; Olivier KR; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
Radiat Oncol; 2015 Feb; 10():43. PubMed ID: 25889747
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
19. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.
Matsuo Y; Shibuya K; Nakamura M; Narabayashi M; Sakanaka K; Ueki N; Miyagi K; Norihisa Y; Mizowaki T; Nagata Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e545-9. PubMed ID: 22436782
[TBL] [Abstract][Full Text] [Related]
20. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
